Telix Pharmaceuticals | TLX - Market Capitalization

Stock Price
9.85
Daily Change
-0.28 -2.76%
Monthly
-10.54%
Yearly
-65.99%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD3.19B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cochlear AUD 19.65B 679.76M Jun/2025
CSL USD 76.3B 60.04B Jun/2025
Integral Diagnostics AUD 1.08B 457.31M Dec/2024
Mayne Pharma AUD 406.23M 2.44M Jun/2025
Medical Developments International AUD 61.96M 16.34M Jun/2025
Mesoblast USD 1.39B 2.16B Jun/2025
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Pacific Edge NZD 194.21M 87.84M Dec/2025
Paradigm Biopharmaceuticals AUD 118.78M 27.21M Jun/2025
Polynovo AUD 825.56M 583.76M Jun/2025
PYC Therapeutics AUD 755.32M 139.4M Jun/2025
ResMed USD 39.31B 13.21B Feb/2026
Sonic Healthcare AUD 12.87B 105.69M Jun/2025